SCHEMBL2982149

SCHEMBL2982149

C=C(C)C(=O)OCCN(CCOC(=O)C(=C)C)c1ccc(N=Nc2ccccc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.44
RAB9A P51151 8/20 0.44
SMN1; SMN2 Q16637 7/20 0.44
NPC1 O15118 7/20 0.44
HPGD P15428 1/20 0.44
ALDH1A1 P00352 7/20 0.41
MAPK1 P28482 4/20 0.41
TDP1 Q9NUW8 3/20 0.41
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MEN1 O00255 7/20 0.40
KMT2A Q03164 7/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
LMNA P02545 3/20 0.40
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
POLB P06746 3/20 0.39
HTT P42858 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13378764 1.00 MAPT (0.44) MAPTRAB9ASMN1; SMN2NPC1HPGD
SCHEMBL15357901 0.94 RAB9A (0.41) MAPTRAB9ASMN1; SMN2NPC1HPGD
SCHEMBL14505212 0.90 MAPT (0.39) MAPTRAB9ASMN1; SMN2NPC1HPGD
SCHEMBL29201258 0.88 MAPT (0.40) MAPTRAB9ASMN1; SMN2NPC1HPGD
SCHEMBL31582668 0.87 POLB (0.44) MAPTSMN1; SMN2ALDH1A1TDP1TSHR
SCHEMBL10119169 0.87 MYC (0.40) MAPTRAB9ASMN1; SMN2NPC1HPGD
SCHEMBL10620844 0.86 MAPT (0.55) MAPTRAB9ASMN1; SMN2NPC1HPGD
SCHEMBL625611 0.84 MMP14 (0.49) MAPTRAB9ASMN1; SMN2NPC1ALDH1A1
SCHEMBL625610 0.84 MMP14 (0.49) MAPTRAB9ASMN1; SMN2NPC1ALDH1A1
SCHEMBL2605872 0.84 MAPT (0.37) MAPTRAB9ASMN1; SMN2NPC1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2081612-B1 INTRAOCULAR LENSES WITH UNIQUE BLUE-VIOLET CUTOFF AND BLUE LIGHT TRANSMISSION CHARACTERISTICS NOVARTIS AG (CH) 2012-11-21 EP claimed
US-7691918-B2 Intraocular lenses with unique blue-violet cutoff and blue light transmission characteristics ALCON, INC. (CH) 2010-04-06 US claimed
EP-2081612-A2 INTRAOCULAR LENSES WITH UNIQUE BLUE-VIOLET CUTOFF AND BLUE LIGHT TRANSMISSION CHARACTERISTICS Alcon Inc. (CH) 2009-07-29 EP claimed
WO-2008048880-A2 INTRAOCULAR LENSES WITH UNIQUE BLUE-VIOLET CUTOFF AND BLUE LIGHT TRANSMISSION CHARACTERISTICS ALCON, INC. (CH) 2008-04-24 WO claimed
US-20080090937-A1 INTRAOCULAR LENSES WITH UNIQUE BLUE-VIOLET CUTOFF AND BLUE LIGHT TRANSMISSION CHARACTERISTICS ALCON MANUFACTURING LTD. (US) 2008-04-17 US claimed
EP-2081612-B1 INTRAOCULAR LENSES WITH UNIQUE BLUE-VIOLET CUTOFF AND BLUE LIGHT TRANSMISSION CHARACTERISTICS NOVARTIS AG (CH) 2012-11-21 EP disclosed
US-7691918-B2 Intraocular lenses with unique blue-violet cutoff and blue light transmission characteristics ALCON, INC. (CH) 2010-04-06 US disclosed
EP-2081612-A2 INTRAOCULAR LENSES WITH UNIQUE BLUE-VIOLET CUTOFF AND BLUE LIGHT TRANSMISSION CHARACTERISTICS Alcon Inc. (CH) 2009-07-29 EP disclosed
WO-2008048880-A2 INTRAOCULAR LENSES WITH UNIQUE BLUE-VIOLET CUTOFF AND BLUE LIGHT TRANSMISSION CHARACTERISTICS ALCON, INC. (CH) 2008-04-24 WO disclosed
US-20080090937-A1 INTRAOCULAR LENSES WITH UNIQUE BLUE-VIOLET CUTOFF AND BLUE LIGHT TRANSMISSION CHARACTERISTICS ALCON MANUFACTURING LTD. (US) 2008-04-17 US disclosed